Credit Suisse Downgrades St. Jude Medical (STJ) to Neutral Follower Takeout
Get Alerts STJ Hot Sheet
Price: $80.82 --0%
Rating Summary:
3 Buy, 21 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
3 Buy, 21 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Credit Suisse downgraded St. Jude Medical (NYSE: STJ) from Outperform to Neutral with a price target of $81.00 (from $67.00) after the company agreed to be acquired by Abbott.
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $76.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
- HSBC Downgrades Kakao Corp. (035720:KS) to Hold
- Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share